Founder, Chief Executive Officer and Director
Ruben Minski, founder, CEO and president of Procaps Group, with extensive experience and recognition in the pharmaceutical industry. Chemical Engineer from Northeastern University in Boston, Massachusetts, he participated in the Owners/President Management program at Harvard University - School of Business, CEOs' II: The Next Step in Strategic Management and in the CEOs' Management Program at Kellogg School of Management at Northwestern University, USA.
President
Dr. Camilo Camacho has over 23 years of experience in the pharmaceutical industry in Latin America, with broad experience in marketing, sales, R&D, operations and quality control. Dr. Camacho has held leadership positions in five different primary care markets: Cardiovascular, CNS, Respiratory, Gastroenterology and Women´s Health. Dr. Camacho served as Head and General Manager of both the Colombia and North Latin America regions at Abbott Laboratories’ Established Pharmaceutical Division (EPD) from 2014 to 2021. There he led the integration of Abbott Laboratories in Colombia after its acquisition of CFR Pharmaceuticals, and after Lafrancol was acquired by CFR in Colombia. He received his Medical Degree from the Escuela Colombiana de Medicina, Colombia, a Specialist in Pharmacology from the Universidad Nacional de Colombia, and an MBA from the INALDE Business School Colombia.
Chief Financial Officer
Patricio Vargas has served as Procaps´ global CFO since August 2021. Mr. Vargas has 25 years of public company finance experience with proven capabilities in global financial management, business development and global capital markets. He joins Procaps after serving as Finance Vice President & Treasurer at Empresas CMPC S.A. (CMPC.CL), a pulp and paper company with more than $5 billion in revenue that produces and markets solid wood products, pulp, paper, tissue, personal care and packaging products in Latin America. Previously, he was Chief Executive Officer at international food processor Agrofoods Central Valley Chile S.A. Prior to that, Mr. Vargas was the CFO of CFR Pharmaceuticals S.A. (“CFR”), and worked directly with then CEO, Alejandro Weinstein, who is currently both a shareholder of Procaps Group and is expected to be the Chairman of its M&A committee. Mr. Vargas previously worked with Mr. Weinstein to lead CFR’s initial public offering in 2011, as well as on over $1 billion of the company’s financings used to fuel its inorganic growth strategy. He graduated as an Industrial and Electrical Engineer from Universidad Católica de Chile, holds an MBA from Universidad Adolfo Ibáñez, Chile, and attended the Advanced Management Program (188) at Harvard Business School, USA.
VP of Finance
Carlos Piocuda Russo, member of the Company's Executive Committee since 2019. Business Administrator with an MBA from Universidad del Norte. He has over 12 years of experience and has led financial and administrative positions in oil and gas entities, as well as in the pharmaceutical industry. His career in the company began as Financial Manager 2015 and he is currently in charge of the Corporate Value Optimization team, managing strategic projects including portfolio optimization, digital transformation and profitability initiatives.
Audit and Internal Corporate Control
Grethel Moreno Romero, Systems Engineer from Universidad del Norte, with specialization in Finance, Senior Management Studies and MBA. Her experience of more than 30 years in management positions in the financial and internal audit areas, in oil and gas and pharmaceutical industries, has allowed her to lead project structuring processes, mergers and acquisitions operations, shareholding sales, syndicated loans with local and international banks, strategic planning, among other responsibilities. As Vice-President of Audit and Internal Control, she has led the establishment of corporate guidelines aimed at strengthening the control system of the organization's processes, within the best international standards. As member of boards of directors of private and solidarity economy companies, she has supported their management from the financial and control perspective.
VP of Legal Affairs
Mauricio Castañeda Caballero, he is a Business Administrator from Universidad de la Sabana and his academic preparation includes a specialization in Strategic Marketing from CESA and an MBA from INALDE. He has over 20 years of experience in the mass consumption, insurance and health sectors, where he has led organizational planning and transformation processes, strategic planning of human talent with emphasis on the design of succession plans, labor legislation and complementary reforms, variable compensation systems, among others.
Corporate Human Resources
Mauricio Castañeda Caballero, he is a Business Administrator from Universidad de la Sabana and his academic preparation includes a specialization in Strategic Marketing from CESA and an MBA from INALDE. He has over 20 years of experience in the mass consumption, insurance and health sectors, where he has led organizational planning and transformation processes, strategic planning of human talent with emphasis on the design of succession plans, labor legislation and complementary reforms, variable compensation systems, among others.
Marketing and R&D
Luis Alberto Palacios Aragon, born in Peru, graduated from the Universidad del Pacifico with a Business Management degree. He later received a Master’s degree in Marketing and Business Management from the American University of Paraguay and leadership training at Kellogg Business School. He has 35 years of varied and extensive experience in the Latin American pharmaceutical sector, executing different commercial roles, managing clients, especially health professionals from different Latin American countries. For 6 years, he has served Procaps Group, leading commercial management and international marketing for the Pharma Business Management in Colombia. In 2019 he assumed the challenge of being the Corporate Vice President of International Marketing and Research and Development, constantly promoting the development of science and innovation.

Investor Contact Information

Company

Procaps Group
9 Rue De Bitbourg
L-1273 Luxembourg
Grand Duchy of Luxembourg

Investor Relations

Procaps Group Company Contact
Melissa Angelini
Investor Relations Director
ir@procapsgroup.com
mangelini@procapsgroup.com

Search Investor Relations